HENRY COKE MORGAN, Jr., Senior District Judge.
This matter is before the Court upon Defendant LifeCell Corp.'s ("Defendant") Motion to Seal Portions of the Trial Transcripts Containing Defendant's Trade Secrets and Third Party Confidential Information ("Motion"). Doc. 425. For the reasons stated herein, the Court DENIES the Motion at this time.
On September 6, 2013, Plaintiff LifeNet Health ("Plaintiff or "LifeNet") filed a one-count Complaint, alleging that Defendant infringed U.S. Patent No. 6,569,200 ("the '200 Patent"). Doc. 1. An eleven-day jury trial commenced on November 3, 2014. On November 18, 2014, the jury returned a verdict in favor of Plaintiff, finding that certain of Defendant's products infringed claims 1, 2, 3, 4, 7, 8, and 10 of the '200 Patent, and that said claims were not invalid as anticipated, obvious, or for lack of enablement. Doc. 369. The jury found that Plaintiff was entitled to a lump sum royalty of $34,741,871.
Prior to trial, Defendant moved on October 30, 2014, to seal documents and close the courtroom during the presentation of confidential material at trial. Doc. 318. The Court denied the Motion at that time, unable to "make the determination that the presence of trade secrets and financial information outweighs the public's First Amendment right to access court proceedings." Doc. 325 at 2. However, upon the showing of a need for sealing, the Court ultimately sealed certain trial exhibits admitted into evidence during the course of the trial. Doc. 410. While the Court never closed the courtroom during the course of the proceedings, the Court placed observers under the Court's previously entered protective order.
The instant Motion was filed on December 19, 2014. Doc. 426. No opposition has been filed by Plaintiff.
"Trial exhibits, including documents previously filed under seal, and trial transcripts will not be filed under seal except upon a showing of necessity demonstrated to the trial judge." Local R. of Civ. P. 5(H). Any motion for a protective order providing prospectively for filing of documents under seal shall be accompanied by a non-confidential supporting memorandum, a notice that identifies the motion as a sealing motion, and a proposed order."
While there is a general common law right of public access to judicial proceedings, the United States Supreme Court has recognized that such right is "not absolute."
In
The Fourth Circuit in
Mindful of the delicate balance between ensuring public access and Defendant's right to the protection of its trade secrets, the Court has taken numerous actions short of closing the entire courtroom. It placed observers under the protective order in this case, sealed exhibits admitted into evidence during the course of trial, sealed exhibits submitted in support of the numerous pre-trial motions, and redacted Court orders to limit the disclosure of sensitive information. The four areas of information that Defendant wishes redacted from the transcript, which covers its preservation technology, its manufacturing processes, information subject to third-rate confidentiality agreements, and information concerning ongoing research and development projects, are consistent with the type of information that the Court has previously sealed or redacted, and is further consistent with the case law.
In the instant Motion, Defendant has identified one hundred and thirty-eight (138) sections of the transcript that it wishes to redact. The problem with the request as currently presented to the Court is that the majority of the requests are not sufficiently narrowly tailored to remove only the confidential information. One passage is illustrative of this problem. Defendant asks the Court to redact the portion of the transcript from page 583, line 23 to page 584, line 3. This particular passage contains the identity of four plasticizers that Defendant wishes redacted. However, in this passage the Court is asking counsel about an important exhibit that showed removal of plasticizer from one of the accused skin grafts. The removal of plasticizer from the skin graft was one of the more important issues in the case. While the Court is inclined to redact the specific identity of the plasticizers, redacting the entirety of this important passage, and others like it, does not give the public an opportunity to truly understand the issues in this case.
Moreover, a less drastic alternative to complete redaction of some of these terms exists. Instead of complete redaction of the specific plasticizers that Defendant wishes redacted, a placeholder such as"plasticizer" or "additive" can be used. Thus, public access is protected in the sense that the public can gain a greater understanding of the case, while protecting Defendant's trade secrets that show the specific amount or specific cocktail of ingredients in its products.
Thus, the Court will
Accordingly, the Court
The Clerk is
It is so